SRXH EMJX Acquisition Puts Eric Jackson in Charge

SRXH EMJX acquisition names Eric M. Jackson CEO and reframes SRx Health as an AI-enabled crypto treasury, creating a shareholder-vote catalyst for traders.

December 16, 2025·2 min read
View all news articles
Flat filled vector of a vault merged with a digital wallet symbolizing SRXH EMJX acquisition and crypto treasury pivot.

KEY TAKEAWAYS

  • SRx Health entered a definitive agreement to acquire EMJX with unanimous board approval.
  • Deal expects close in Q1 2026 subject to shareholder approval and customary conditions.
  • Eric M. Jackson will become CEO and chairman; combined company to rebrand under EMJX.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

SRXH EMJX acquisition announced Dec. 16, 2025 will make Eric M. Jackson chief executive and chairman of the combined company and signals SRx Health Solutions Inc. (NYSE American: SRXH)’s pivot from healthcare into a quantitative, AI-enabled digital-asset treasury platform.

Deal Timeline, Approvals, and Leadership

SRx Health Solutions said in a Dec. 16, 2025 press release that it has entered into a definitive agreement to acquire EMJ Crypto Technologies Inc. (EMJX) and CCC Crypto Corp., describing the transaction as transformative for its business mix. The SRx Health board unanimously approved the deal.

The transaction is expected to close in the first quarter of 2026, subject to SRx Health shareholder approval and customary closing conditions. Upon completion, the combined company plans to operate under the EMJX name and intends to pursue a ticker-symbol change on the NYSE American.

The company said, "Upon closing, Eric M. Jackson will lead the combined company as Chief Executive Officer and Chairman." Jackson, a fund manager and activist investor, is the principal behind EMJX’s crypto treasury strategy.

The deal is structured as a reverse-merger-style pivot, with EMJX’s business becoming the primary operating entity of the listed SRXH company. This shifts SRx Health’s legacy healthcare and pet wellness operations toward a quantitative, AI-enabled digital-asset treasury platform focused on institutional-grade management.

EMJX’s platform combines quantitative trading and allocation strategies with AI-driven risk management, emphasizing public-market governance and transparency. The combined company aims to position itself at the intersection of public-market governance and advanced digital-asset treasury management.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Read other top news stories

Nvidia Revenue Forecast Supports Growth Case

Nvidia Revenue Forecast Supports Growth Case

Nvidia revenue forecast drew focus after fiscal-2026 results and $78 billion guidance and could shape near-term positioning on AI data-center demand.

Palantir Guidance PLTR Spurs AI Deal Speculation

Palantir Guidance PLTR Spurs AI Deal Speculation

Palantir guidance ties FY2026 growth to the DoD Maven program of record and renewed auto partnerships that bolster pipeline and trader positioning.

Micron Earnings Hit Record Q2 Results

Micron Earnings Hit Record Q2 Results

Micron earnings topped forecasts with a record Q2 and higher Q3 guidance, prompting traders to weigh upside versus heavy capex and cash-flow risk.

Cal-Maine Q3 Results Show Sales Pressure

Cal-Maine Q3 Results Show Sales Pressure

Cal-Maine Q3 results showed sales down as egg prices normalized and EPS beat while a pivot to specialty and prepared foods may steady earnings and trading

Lamb Weston Earnings Lift Guidance, Cut Capex

Lamb Weston Earnings Lift Guidance, Cut Capex

Lamb Weston earnings beat adjusted EPS and lifted FY2026 sales midpoint while cutting capex to ~$400M, shifting investor focus toward cash generation.

SpaceX IPO Files Confidential SEC Submission

SpaceX IPO Files Confidential SEC Submission

SpaceX IPO confidential filing signals a $75B raise and $1.75T target valuation that could shift capital into satellite and AI infrastructure